IRIS UniCatt

Metafuni, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.257
AS - Asia 2.982
EU - Europa 2.569
SA - Sud America 579
AF - Africa 92
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.485
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.153
SG - Singapore 1.405
CN - Cina 729
DE - Germania 625
IT - Italia 479
BR - Brasile 466
SE - Svezia 453
FR - Francia 291
VN - Vietnam 257
GB - Regno Unito 163
IE - Irlanda 125
IN - India 116
FI - Finlandia 101
ID - Indonesia 89
UA - Ucraina 76
JP - Giappone 74
RU - Federazione Russa 65
HK - Hong Kong 52
CA - Canada 50
KR - Corea 46
AR - Argentina 36
MX - Messico 36
BD - Bangladesh 34
NL - Olanda 34
IQ - Iraq 31
PL - Polonia 30
TR - Turchia 29
ZA - Sudafrica 25
AT - Austria 24
BE - Belgio 21
CI - Costa d'Avorio 21
CO - Colombia 19
SA - Arabia Saudita 19
CZ - Repubblica Ceca 16
EC - Ecuador 15
ES - Italia 14
CL - Cile 11
MA - Marocco 11
UZ - Uzbekistan 11
VE - Venezuela 11
KE - Kenya 9
PK - Pakistan 9
UY - Uruguay 9
PH - Filippine 8
TH - Thailandia 8
DZ - Algeria 7
JO - Giordania 7
PY - Paraguay 7
SN - Senegal 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
IL - Israele 6
NP - Nepal 6
LT - Lituania 5
RO - Romania 5
AM - Armenia 4
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
EG - Egitto 4
IR - Iran 4
JM - Giamaica 4
LV - Lettonia 4
PT - Portogallo 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
KZ - Kazakistan 3
LB - Libano 3
QA - Qatar 3
AO - Angola 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
KG - Kirghizistan 2
LI - Liechtenstein 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KI - Kiribati 1
Totale 9.476
Salva come PNG Salva come JPEG
Città #
Singapore 788
Chandler 402
San Jose 358
Ashburn 316
Beijing 145
Dublin 123
Hefei 122
Rome 110
Los Angeles 103
New York 86
Lauterbourg 85
Jakarta 82
Munich 81
Ho Chi Minh City 79
Frankfurt am Main 76
Milan 75
Tokyo 73
Dallas 70
Hanoi 70
San Mateo 68
The Dalles 65
Jacksonville 62
Houston 59
Chicago 58
Hyderabad 53
Florence 49
Nanjing 49
Council Bluffs 48
Dearborn 48
Helsinki 46
Hong Kong 46
São Paulo 46
Seoul 44
Marseille 43
Ann Arbor 42
Wilmington 38
Moscow 37
Kent 36
Santa Clara 36
Boston 35
Lancaster 34
Princeton 33
Cattolica 30
Nürnberg 29
Buffalo 27
London 27
Seattle 27
Bremen 26
Nuremberg 26
Orem 26
Lappeenranta 25
Nanchang 22
Abidjan 21
Brussels 21
Warsaw 21
Toronto 20
Rio de Janeiro 19
Tianjin 19
Atlanta 18
Guangzhou 18
Shanghai 18
Paris 17
Stockholm 17
Denver 16
Johannesburg 16
Poplar 16
Belo Horizonte 15
Izmir 15
Phoenix 15
Woodbridge 15
Amsterdam 14
Boardman 14
Brooklyn 14
Turku 14
Washington 14
Fairfield 13
Lawrence 13
Montreal 13
Pune 13
Brno 12
Curitiba 12
Vienna 12
Augusta 11
Baghdad 11
Da Nang 11
Dhaka 11
Haiphong 11
Mexico City 11
Naples 11
Norwalk 11
Portsmouth 11
San Francisco 11
Düsseldorf 10
Redwood City 10
Tashkent 10
Bexley 9
Campinas 9
Charlotte 9
Chennai 9
Manchester 9
Totale 5.244
Salva come PNG Salva come JPEG
Nome #
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 230
Correlation between paraproteinaemia and viral reactivation after allo-SCT 215
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 187
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 179
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 176
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 169
Hyperleukocytosis and leukostasis: management of a medical emergency 159
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 157
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 157
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 151
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 147
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 147
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 145
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 143
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 140
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 139
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 136
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 135
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 132
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 131
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 130
MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings 127
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 127
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 126
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 125
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 121
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 121
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 119
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 119
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 116
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review 115
Changes in protein serum levels during stem cell transplantation 115
Unrelated cord blood transplantation and post-transplant cyclophosphamide 115
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 113
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 112
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 112
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 111
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 109
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 109
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 109
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 107
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 106
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 106
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 106
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 106
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 106
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 105
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 y with Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study 102
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 102
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 100
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients 100
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 99
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 99
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 95
Unrelated cord blood transplantation and post-transplant cyclophosphamide 95
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 94
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 94
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 93
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 89
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center 89
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 89
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 89
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 89
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 88
The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience 86
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 82
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 81
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 81
Second haploidentical stem cell transplantation for primary graft failure 80
Reducing infectious complications after allogeneic stem cell transplant 78
Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis 77
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 76
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 76
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants 76
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation 74
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 73
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience 71
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 67
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 66
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 64
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 62
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 59
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 54
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? 49
Saprochaete clavata infection in immunosuppressed patients: Systematic review of cases and report of the first oral manifestation, focusing on differential diagnosis 30
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 29
Totale 9.646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.054
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 72 7
2021/2022488 34 14 29 24 43 12 9 72 19 45 98 89
2022/20231.216 188 159 72 185 85 135 88 84 102 51 54 13
2023/2024776 29 156 45 60 21 94 65 43 17 56 85 105
2024/20251.997 47 52 127 101 170 65 89 85 215 218 472 356
2025/20263.924 616 146 319 471 627 231 650 229 324 278 33 0
Totale 9.646